Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
This study is not yet open for participant recruitment.
Verified March 2012 by Beijing Northland Biotech. Co., Ltd.
Sponsor:
Beijing Northland Biotech. Co., Ltd.
Collaborator:
ViroMed Co., Ltd.
Information provided by (Responsible Party):
Beijing Northland Biotech. Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01548378
First received: March 5, 2012
Last updated: April 9, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |